These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24153415)

  • 1. Lipoprotein(a): the underestimated cardiovascular risk factor.
    Thompson GR; Seed M
    Heart; 2014 Apr; 100(7):534-5. PubMed ID: 24153415
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipoprotein(a) as a cardiovascular risk factor].
    van Lennep JE; Mulder MT
    Ned Tijdschr Geneeskd; 2011; 155(42):A3582. PubMed ID: 22027461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnostic significance of lipoprotein(a)].
    Mayer J; Brauer P; Solleder EM
    Dtsch Med Wochenschr; 1992 Nov; 117(48):1845-8. PubMed ID: 1451650
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela.
    Souki-Rincón A; Urdaneta J; Mengual E; Torres D; Cano-Peñaloza R; García-Camacho D; Bermúdez-Pírela V; Sorell L; Cano-Ponce C; Almarza J; Israili Z; Hernández-Hernandez R; Velasco M
    Am J Ther; 2008; 15(4):403-8. PubMed ID: 18645346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial Lp(a) - the underestimated cardiovascular risk factor.
    Mellwig KP
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):1. PubMed ID: 28236286
    [No Abstract]   [Full Text] [Related]  

  • 6. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].
    de Brouckère V; Liénart F; Ducobu J
    Rev Med Brux; 2010; 31(3):171-6. PubMed ID: 20687444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein(a) and the cardiovascular risk].
    Pedro-Botet J; Sentí M
    Rev Esp Cardiol; 1994 Sep; 47(9):583-6. PubMed ID: 7973023
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].
    Couderc R; Maachi M
    J Mal Vasc; 1998 Jun; 23(3):165-75. PubMed ID: 9669219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) and cardiovascular risk in adult Mexicans.
    Cardoso-Saldaña G; Ize-Lema I; Kimura LY; Zamora González J; Posadas Romero C
    Rev Invest Clin; 1997; 49(2):85-92. PubMed ID: 9294956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein (a) - what to do?].
    Waldmann E
    MMW Fortschr Med; 2018 Jan; 160(1):46-49. PubMed ID: 29335942
    [No Abstract]   [Full Text] [Related]  

  • 11. Lp(a) lipoprotein--coping with heterogeneity.
    Scanu AM
    N Engl J Med; 2003 Nov; 349(22):2089-90. PubMed ID: 14645635
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence, guidelines and recommendations.
    Lippi G; Franchini M; Targher G
    Clin Chim Acta; 2011 May; 412(11-12):797-801. PubMed ID: 21256836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and Lp(a) in the adult population and in the elderly: the Brisighella study.
    Nascetti S; D'Addato S; Pascarelli N; Sangiorgi Z; Grippo MC; Gaddi A
    Riv Eur Sci Med Farmacol; 1996; 18(5-6):205-12. PubMed ID: 9177623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) and ageing.
    Lippi G; Targher G; Salvagno GL; Montagnana M; Franchini M; Guidi GC
    Clin Lab; 2010; 56(9-10):463-6. PubMed ID: 21086792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein(a) in children with hypercholesterolemia as a marker of the familial history of cardiovascular risk. The Working Group on Cardiovascular Risk Factors in Childhood and Adolescence].
    Sánchez Bayle M; Baeza Mínguez J; Vila Dupla S; Ruiz-Jarabo Quemada C; Asensio Antón J; Arnaiz P; Martín F
    An Esp Pediatr; 1996 Jul; 45(1):53-6. PubMed ID: 8849131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do we know about lipoprotein(a)?
    Cybulska B; Kłosiewicz-Latoszek L
    Kardiol Pol; 2015; 73(4):235-9. PubMed ID: 25563463
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney disease.
    Kronenberg F
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):729-43. PubMed ID: 15350174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a): a unique risk factor for cardiovascular disease.
    Anuurad E; Boffa MB; Koschinsky ML; Berglund L
    Clin Lab Med; 2006 Dec; 26(4):751-72. PubMed ID: 17110238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) and family history of cardiovascular disease in children with familial dyslipidemias.
    Guardamagna O; Abello F; Anfossi G; Pirro M
    J Pediatr; 2011 Aug; 159(2):314-9. PubMed ID: 21392785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The smoking gun of cardiovascular diseases? The great interest in Lp(a)-lipoprotein].
    Dahlén GH
    Lakartidningen; 1993 Jan; 90(4):259-62. PubMed ID: 8433604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.